First human test of CAR-T therapy targets tough digestive cancers
NCT ID NCT06197178
Summary
This early-stage study tested a new type of personalized immune cell therapy called LCAR-G08 in 17 adults with advanced cancers of the digestive system (like colorectal or stomach cancer). The main goals were to find the safest dose and see how well the body handled the treatment. Researchers also checked if the therapy could help shrink the participants' tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED GASTROINTESTINAL TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Cancer Hospital & Institute
Beijing, Beijing Municipality, 100142, China
-
Beijing GoBroad Hospital
Beijing, Beijing Municipality, 102200, China
Conditions
Explore the condition pages connected to this study.